Advertisement
Neutrophils and lung injury: getting it right
Thomas R. Martin
The Medical Research Service of the VA Puget Sound Medical Center, and the Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Washington School of Medicine, Seattle, Washington, USA
Address correspondence to: Thomas R. Martin, Pulmonary Research, 151L, VA Puget Sound Medical Center, 1660 South Columbian Way, Seattle, Washington 98108, USA. Phone: (206) 764-2219; Fax: (206) 768-5289; E-mail: trmartin@u.washington.edu.
Find articles by Martin, T. in: JCI | PubMed | Google Scholar
Published December 1, 2002 - More info
J Clin Invest. 2002;110(11):1603–1605. https://doi.org/10.1172/JCI17302.
© 2002 The American Society for Clinical Investigation
Acute lung injury (ALI) is common in critically ill patients, and there has been a great deal of interest in the cellular and molecular mechanisms linking mechanical ventilation with ALI. Although it is possible to ventilate patients with normal lungs for prolonged periods of time without causing lung injury, a landmark controlled randomized clinical trial in critically ill patients with ALI showed that mechanical ventilation with a lung protective strategy improves outcome as compared with conventional mechanical ventilation (1). This trial was based on a series of studies in animals and humans suggesting that mechanical ventilation could injure the lungs, as measured by a number of different parameters (2, 3). In a separate study of humans with ALI, a lung protective strategy reduced cellular and biochemical parameters of the inflammatory response in the lungs, suggesting a key link between the mode of mechanical ventilation and inflammation observed in the lungs (4). The consistent association between polymorphonuclear neutrophils (PMNs) and lung injury in humans and animal models, and the propensity of PMNs and their products to cause tissue injury in experimental systems, led to the conclusion that PMNs have an important causative role in ALI (5, 6). Neutrophil depletion is protective in many animal models of ALI, and blocking the major PMN chemoattractant, IL-8, protects rabbits from lung injury and death following severe acid aspiration (pH 1.5) (7). Yet the results of these studies leave some questions unanswered, because none of the models closely simulate the events that occur in the injured lungs of humans. Although direct studies in humans are very limited, PMNs migrate into normal human lungs in response to an intra-alveolar chemoattractant without causing injury, and without undergoing significant degranulation (8). In addition, studies using G-CSF to augment host defenses in humans with severe pneumonia and sepsis showed that increasing the circulating PMN count to high levels was not associated with worsening clinical manifestations of lung injury (9, 10). Similarly, studies in sheep using the bidirectional movement of alveolar and vascular tracers showed that large numbers of PMNs migrate into the lungs in response to bacterial lipopolysaccharide without injuring the critical epithelial barrier of the lungs, even though endothelial permeability is increased (11). Careful ultrastructural studies in rabbits and mice have shown that PMNs migrate through specialized channels in endothelial and epithelial basement membranes and into the alveolar spaces in areas of streptococcal pneumonia without causing apparent damage to these barriers (12). Taking a different approach, a study of the metabolic activity of lung PMNs in rabbits with streptococcal pneumonia showed that the most metabolically active PMNs are in the alveolar spaces, and not in the microvasculature or the interstitium, suggesting that the major activation events occur in the alveolar spaces in response to bacteria, and not during migration (13).
-
A link between PMNs and ventilator-induced lung injury
Recognizing that none of the existing models are a perfect match for human disease, the resolution of these discrepant observations will require careful studies in experimental systems in which single variables can be manipulated. In this issue of the JCI, Belperio and colleagues take a molecular approach to studying the role of PMNs in ventilator-induced lung injury (VILI), using a scientifically straightforward but technically challenging model of VILI in mice mechanically ventilated with either small or large tidal volumes (14). The small tidal volumes and high respiratory rates of mice necessitate careful monitoring of systemic hemodynamics in order to ensure that the ventilatory protocols do not adversely affect hemodynamic parameters. An important consideration is that acute inflammatory mechanisms in mice differ in important ways from those of humans. For example, human PMNs express two major α-chemokine receptors, CXCR1 and CXCR2, providing overlapping effector pathways for chemotaxis, whereas murine PMNs express only CXCR2, and lack CXCR1, which is the dominant chemotactic receptor for IL-8 on human PMNs. In addition, the inducible nitric oxide pathway is much more active in murine than in human macrophages. Belperio et al. exploited the lack of murine CXCR1 and the availability of CXCR2 knockout mice to test the role of PMN migration mediated by CXCR2 and its related ligands in the murine VILI model (14). Over a 6 hour period, the higher tidal volume strategy caused an increase in lung microvascular permeability, indicated by an increase in the extravasation of Evans blue dye into lung tissue, and an increase in the lung wet:dry ratio, which reflects extravascular lung water (Figure 1). Light microscopy showed alveolar flooding, PMN infiltration, and areas of alveolar hemorrhage. The myeloperoxidase content increased in lung homogenates suggesting PMN entrapment, and CXCR2 expression increased on leukocytes and other cells in the lungs. These findings were associated with an increase in CXCR2 ligands in lung tissue, and evidence of IκB phosphorylation and degradation, suggesting an increase in NFκB-dependent gene transcription. These effects were reduced by using inhibitory antibodies to block the effects of CXCR2 ligands, and also by specific antibodies to CXCR2. Importantly, the authors found an even greater degree of protection against VILI in mice lacking CXCR2.
Figure 1The normal alveolus (left side) and polymorphonuclear neutrophil (PMN) migration into alveolar spaces during a murine model of ventilator-induced lung injury (right side). Shown are the two critical barriers, the endothelium and epithelium. PMNs adhere to the capillary endothelium and migrate through the interstitium and the epithelium into the fluid-filled alveolar airspace. Alveolar macrophages secrete cytokines and interleukins that activate local neutrophils. In humans there are two major CXC receptors with overlapping ligands (CXCR1/IL-8; CXCR2/IL-8, GRO peptides, ENA-78). Mice have only CXCR2 (CXCR2/KC, MIP-2). The ligands are produced by alveolar macrophages and other cells in the lungs.
Copyright © 2024 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)